XML 74 R59.htm IDEA: XBRL DOCUMENT v3.21.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Nov. 24, 2020
USD ($)
$ / shares
shares
Dec. 18, 2019
Sep. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
Subsidiary, Sale of Stock [Line Items]                  
Number of warrants to purchase shares issued | shares     6,439 6,439     6,439    
Cash held outside the Trust Account     $ 7,996,362 $ 32,478,948     $ 7,996,362   $ 27,787,314
Cash of not held in the trust account and available for working capital purposes             (5,566,182)    
LifeSci Acquisition II Corp                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Units, net of underwriting discounts and offering expenses (in shares) | shares       8,009,041          
Proceeds from sale of Private Placement Warrants               $ 2,831,809  
Transaction Costs $ 1,858,498                
Underwriting fees 1,601,808                
Other offering costs $ 256,690                
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account               80.00%  
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination               50.00%  
Cash held outside the Trust Account     200,897     $ 25,000 $ 200,897 $ 416,111  
Cash of not held in the trust account and available for working capital purposes     $ 200,897         416,111  
Aggregate purchase price           $ 25,000      
Proceeds from Related Party Debt         $ 175,000     175,000  
Condition for future business combination number of businesses minimum   1              
Payments for investment of cash in Trust Account               80,090,412  
Working capital subject to annual limit               250,000  
Condition for future business combination threshold Net Tangible Assets               $ 5,000,001  
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent               20.00%  
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)               100.00%  
Threshold business days for redemption of public shares               5 days  
Initial Public Offering | LifeSci Acquisition II Corp                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Units, net of underwriting discounts and offering expenses (in shares) | shares 8,009,041                
Purchase price, per unit | $ / shares $ 10.00                
Payments for investment of cash in Trust Account $ 80,090,412                
Private Placement | Private Placement Warrants | LifeSci Acquisition II Corp                  
Subsidiary, Sale of Stock [Line Items]                  
Number of warrants to purchase shares issued | shares 3,146,454   3,146,454       3,146,454 3,146,454  
Price of warrant | $ / shares $ 0.90   $ 0.90       $ 0.90 $ 0.90  
Proceeds from sale of Private Placement Warrants $ 2,831,809   $ 2,831,809         $ 2,831,809  
Over-allotment option | LifeSci Acquisition II Corp                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of Units, net of underwriting discounts and offering expenses (in shares) | shares 509,041                
Purchase price, per unit | $ / shares $ 10.00   $ 10.00       $ 10.00 $ 10.00  
Proceeds from issuance initial public offering $ 80,090,410